Inventor · disambiguated record
Wen-Cherng Lee
Also filed as: LEE WEN-CHERNG
31 granted patents·20 pending applications·220 citations·filing 1995–2024
97Inventor score
Files withBIOGEN IDEC INC12KANGPU BIOPHARMACEUTICALS LTD12BIOGEN INC10SUNESIS PHARMACEUTICALS INC5LEE WEN-CHERNG3
Top patents by PatentIndex Score
51 records- 0189US8778977B2Pyridinonyl PDK1 inhibitorsLIND KENNETH EGNARD·Filed 2007·Granted Jul 15, 2014·21 cites·15 claims
- 0287US10017492B2Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2015·Granted Jul 10, 2018·9 cites·23 claims
- 0385US11001566B2Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applicationsKANGPU BIOPHARMACEUTICALS LTD·Filed 2017·Granted May 11, 2021·3 cites·17 claims
- 0484US9181191B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2012·Granted Nov 10, 2015·3 cites·38 claims
- 0584US2024294524A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0682US8349849B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2009·Granted Jan 8, 2013·6 cites·21 claims
- 0780US10030016B2Heterocyclic compounds useful as PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 24, 2018·2 cites·16 claims
- 0880US6495525B1VLA-4 inhibitor: oMePUPA-VBIOGEN INC·Filed 2000·Granted Dec 17, 2002·13 cites·19 claims
- 0980US6306840B1Cell adhesion inhibitorsBIOGEN INC·Filed 1995·Granted Oct 23, 2001·38 cites·38 claims
- 1079US6630512B2Cell adhesion inhibitorsBIOGEN INC·Filed 2001·Granted Oct 7, 2003·9 cites·53 claims
- 1179US6624152B2Cell adhesion inhibitorsBIOGEN INC·Filed 2001·Granted Sep 23, 2003·9 cites·34 claims
- 1279US6596687B1Cell adhesion inhibitorsBIOGEN INC·Filed 2000·Granted Jul 22, 2003·12 cites·46 claims
- 1378US7196112B2Cell adhesion inhibitorsBIOGEN IDEC INC·Filed 2004·Granted Mar 27, 2007·4 cites·87 claims
- 1478US7001921B1Cell adhesion inhibitorsBIOGEN IDEC INC·Filed 2003·Granted Feb 21, 2006·7 cites·9 claims
- 1578US2024173312A1Pharmaceutical Composition Comprising a Benzoheterocyclic Compound and Androgen Receptor Pathway Modulator and Application ThereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1677US8546359B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2012·Granted Oct 1, 2013·4 cites·31 claims
- 1777US2024139156A1Combination treating prostate cancer, pharmaceutical composition and treatment methodKANGPU BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1874US8269043B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2009·Granted Sep 18, 2012·2 cites·19 claims
- 1974US6376538B1Cell adhesion inhibitorsBIOGEN INC·Filed 1996·Granted Apr 23, 2002·26 cites·56 claims
- 2073US6630503B1Cell adhesion inhibitorsBIOGEN INC·Filed 2000·Granted Oct 7, 2003·5 cites·7 claims
- 2171US6875743B1Cell adhesion inhibitorsBIOGEN INC·Filed 2000·Granted Apr 5, 2005·3 cites·38 claims
- 2270US9546165B2Heterocyclic compounds useful as PDK1 inhibitorsARNDT JOSEPH·Filed 2010·Granted Jan 17, 2017·2 cites·12 claims
- 2370US2021070752A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2469US7691865B2Pyrazolopyridines and methods of making and using the sameBIOGEN IDEC INC·Filed 2003·Granted Apr 6, 2010·5 cites·11 claims
- 2569US7612094B2Tri-substituted heteroaryls and methods of making and using the sameBIOGEN IDEC INC·Filed 2003·Granted Nov 3, 2009·6 cites·21 claims
- 2668US7034043B2Cell adhesion inhibitorsBIOGEN IDEC INC·Filed 2003·Granted Apr 25, 2006·3 cites·5 claims
- 2767US11628161B2Isoindoline derivative, pharmaceutical composition and use thereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2022·Granted Apr 18, 2023·0 cites·16 claims
- 2866US2021267946A1Combination treating prostate cancer, pharmaceutical composition and treatment methodKANGPU BIOPHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2964US2021113545A1Pharmaceutical Composition Comprising a Benzoheterocyclic Compound and Androgen Receptor Pathway Modulator and Application ThereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 3063US2019119268A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3162US11702399B2Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applicationsKANGPU BIOPHARMACEUTICALS LTD·Filed 2021·Granted Jul 18, 2023·0 cites·10 claims
- 3262US9873693B2Methods of treatment using pyridinonyl PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2014·Granted Jan 23, 2018·0 cites·15 claims
- 3360US10081646B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·0 cites·26 claims
- 3460US6248713B1Cell adhesion inhibitorsBIOGEN INC·Filed 1995·Granted Jun 19, 2001·16 cites·13 claims
- 3560US2018370966A1Methods of treatment using pyridinonyl pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3659US6239108B1Cell adhesion inhibitorsBIOGEN INC·Filed 1996·Granted May 29, 2001·12 cites·49 claims
- 3759US2020000776A1Combination treating prostate cancer, pharmaceutical composition and treatment methodKANGPU BIOPHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 3856US2006166866A1Cell adhesion inhibitorsBIOGEN INC A MASSACHUSETTS COR·Filed 2003·Application pending·0 cites
- 3955US9708353B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Jul 18, 2017·0 cites·29 claims
- 4055US2006166961A1Cell adhesion inhibitorsBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 4154US2007066533A1Cell adhesion inhibitorsLEE WEN-CHERNG·Filed 2006·Application pending·0 cites
- 4251US2010105714A1Furanone Compounds and Methods of Making and Using The SameBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 4350US10933059B2Combination, application thereof and treatment methodKANGPU BIOPHARMACEUTICALS LTD·Filed 2017·Granted Mar 2, 2021·0 cites·17 claims
- 4449US11337964B2Isoindoline derivative, pharmaceutical composition and use thereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2018·Granted May 24, 2022·0 cites·16 claims
- 4549US2018271849A1Pharmaceutical composition and application thereofKANGPU BIOPHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 4649US2010035918A1Imidazolone Compounds and Methods of Making and Using the SameBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 4748US2010056505A1Substituted PyrazalonesBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 4843US2006264440A1Pyrazoles and methods of making and using the sameBIOGEN IDEC INC·Filed 2004·Application pending·0 cites
- 4941US2010166819A1Transforming Growth Factor ModulatorsBIOGEN IDEC MA INC A CORP·Filed 2006·Application pending·0 cites
- 5041US2006135517A1Imidazolopyridines and methods of making and using the sameLEE WEN-CHERNG·Filed 2003·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wen-Cherng Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →